跳至主要内容
临床试验/CTRI/2022/03/040982
CTRI/2022/03/040982尚未招募未知

To evaluate the add-on effect of takra sevan along with navaka guggulu in the management of hyperlipidemia a randomized controlled open labellled trial

All India Institute of Ayurveda0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patient with any of the borderline elevated lipid levels and low HDL levels. Patient willing to participate in study.

排除标准

  • Chronicity for more than five years. Patient with cardiovascular disease and other severe conditions like asthma, Diabetes Mellitus, psychological disorders. Patient with allergic conditions like rhinitis and sinusitis. Pregnant women and lactating mother. Patient not able to consume drug on their own as in case of patients with paralysis.

研究者

相似试验